|

Active Surveillance and Safety/Efficacy Evaluation of Innovative Devices for Structural Heart Disease Intervention

RECRUITINGSponsored by Shanghai Jiao Tong University School of Medicine
Actively Recruiting
SponsorShanghai Jiao Tong University School of Medicine
Started2025-12-30
Est. completion2029-01-31
Eligibility
Age18 Years+
Healthy vol.Accepted

Summary

This study aims to establish an active surveillance system to evaluate the safety and effectiveness of innovative medical devices used in the interventional treatment of structural heart disease. The devices of interest include a biodegradable patent foramen ovale (PFO) closure device and a transcatheter mitral valve edge-to-edge repair system. Clinical information from patients receiving these devices during routine clinical care will be collected and analyzed. The findings will help evaluate the safety and effectiveness of these devices and support the development of appropriate clinical evaluation indicators and long-term monitoring strategies.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

1. Patients undergoing implantation of a biodegradable PFO closure device.
2. Patients undergoing transcatheter mitral valve edge-to-edge repair.

Exclusion Criteria:

The participant expresses a desire to withdraw from the study.

Conditions3

Biodegradable Patent Foramen Ovale Closure DeviceHeart DiseaseTranscatheter Mitral Valve Edge-to-Edge Repair System

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.